Heart Failure Risk and Events in People With HIV: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)

By sjmartinez • December 30, 2025

Bloomfield GS, Watanabe M, McCallum S, Aberg JA, Awwad A, Campbell TB, Cespedes MS, Chu SM, Currier JS, Diggs MR, Sponseller CA, Fichtenbaum CJ, Lu MT, Malvestutto CD, Pierone G, Rhame F, Tuan J, Zhao S, Zanni MV, Grinspoon SK, Ribaudo HJ, Douglas PS. Heart Failure Risk and Events in People With HIV: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE). Circ Heart Fail. 2025 Dec 29:e013382. doi: 10.1161/CIRCHEARTFAILURE.125.013382. Epub ahead of print. PMID: 41457980.

Tags: cardiovascular disease, cell count, heart failure, Hypertension, Infectious Diseases, Obesity, Publications

Distinct inflammatory marker profiles of adolescents and young adults among the HIV risk, infection, and treatment spectrum

Dong HV, Salem GM, Kerin T, Tang KH, Cortado R, Shin-Sim M, Arnold EM, Swendeman D, Tobin NH, Rimoin AW, Aldrovandi GM, Yang OO, Bryson[...]

MUCOR-ADVANCE: Uniting multidisciplinary science to defeat a deadly fungus

Wurster S, Stewart AG, Gu Y, Youssef EG, John TM, Uppuluri P, Chamilos G, Filler S, Bruno V, Ibrahim AS, Kontoyiannis DP; MUCOR-ADVANCE consortium. MUCOR-ADVANCE:[...]

“We’ll Just Warm Ourselves up with Drugs”: Polysubstance Use among Sexual and Gender Minority Persons (SGMP) Who Inject Drugs in Los Angeles, California

Smeltzer RP, Orta Portillo GA, Ganesh SS, Koerber J, Gould EE, Bolanos R, Gorbach PM, Bluthenthal RN. "We'll Just Warm Ourselves up with Drugs": Polysubstance[...]